Strengths of our study include the utilization of a hypothesis-driven training–validation approach for evaluation of CSF-1R expression and the large size of the BC Cancer cohort, for there exist previously generated extensive data relevant to immune biomarkers. This evidence concerns the gene CSF1R and breast cancer.